Navigation Links
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
Date:7/2/2009

nnovations in patients with atrial fibrillation in the last twenty years.

The efficacy and safety of Multaq(R) 400 mg twice daily was evaluated in five controlled studies, ATHENA, ANDROMEDA, EURIDIS, ADONIS, and DAFNE, involving nearly 6,300 patients including more than 3200 patients who received Multaq(R).

The ATHENA trial, which involved 4,628 patients with AF or AFL and more than 2,300 patients receiving Multaq(R) on top of standard therapy, demonstrated a 24% reduction in time to first CV hospitalization or all-cause mortality (P<0.001) compared with placebo meeting the primary endpoint.

The ANDROMEDA study, was terminated prematurely after enrolment of 627 of 1000 planned patients with congestive heart failure, in relation to excess mortality due to worsening heart failure in the dronedarone group [n=25 versus 12 (placebo), p=0.027].

The patient population enrolled in the ANDROMEDA and ATHENA studies was significantly different. The patients enrolled in ANDROMEDA had relatively severe heart failure and had been hospitalized, or referred to a specialty heart failure clinic for worsening symptoms. Patients were predominantly NYHA II and III (New York Heart Association classification) and only 25% had a history of AF/AFL at randomization. In contrast, in ATHENA, all patients had a history of AF/AFL, and 71% of patients had no heart failure, 25% were NYHA class I or II, and only 4% were class III.

The ANDROMEDA and ATHENA trials were published in the New England Journal of Medicine (NEJM) respectively in 2008 and 2009.

Important Safety Information

Multaq(R) is contraindicated in patients with NYHA Class IV heart failure or NYHA Class II-III heart failure with a recent decompensation requiring hospitalization or referral to a specialized heart failure clinic. In a placebo-controlled study in patients with severe heart failure requiring recent
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
2. FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
3. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
4. ClearWay Minnesota(SM) Board Approves Four Regional Grants
5. Department of Defense Approves ISSA as Fitness Education Provider to Military Spouses
6. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
7. Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
8. FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
9. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
10. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
11. FDA Approves Plan B Pill for 17-Year-Olds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Lady of Lourdes Health Care Services Inc., the parent ... pay the United States $7.95 million to resolve allegations ... today. The two hospitals are Our Lady of Lourdes ... Center of Burlington County (LMC) in Willingboro, N.J. ... by a whistleblower, Tony Kite, in 2005. The lawsuit ...
(Date:12/15/2009)... risk, research finds , , TUESDAY, Dec. 15 (HealthDay News) ... regulates appetite, may guard against Alzheimer,s disease, new research ... may be one of many agents that we use ... study author Dr. Sudha Seshadri, an associate professor of ... may be one of many markers that we measure ...
(Date:12/15/2009)... American Diabetes Association and the CDC have released some sobering statistics ... United States. Treadmill desks offer employers an effective means of combating ... ... (Vocus) December 14, 2009 -- Rates of diabetes are climbing across ... obesity rates. Despite this rise the American Diabetes Association has stated ...
(Date:12/15/2009)... PARK, Calif., Dec. 15 ... position in the pharmaceutical and bio-tech research ... Marketing Research). Over the past 11 years ... the Physicians Consulting Network (PCN®), which now ... professionals covering both primary care and hard-to-reach ...
(Date:12/15/2009)... 15 Patient advocate ... Members of Congress that, "it doesn,t matter whether there,s ... - without a public option - give government authority ... also fund a new social agenda by shifting billions ... groups, newly arriving immigrants, and local politicians." ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2
... Avon Global Center for Women and Justice at ... Trust Fund to End Violence Against Women Award-Winning Actress ... 3 One in three women worldwide experience violence ... is assaulted every nine seconds(2). Around the world, services ...
... wristbands enable fast and reliable patient identification at ... Zebra Technologies (Nasdaq: ZBRA ), ... solutions for the healthcare industry, has introduced a ... Z-Band QuickClip wristbands for infants to ensure comfort ...
... In 2006, Americans were exposed to more than seven ... was the case in the early 1980s, according to ... by the National Council on Radiation Protection and Measurements ... 2006, medical exposure constituted nearly half of the total ...
... mouse study finds , , TUESDAY, March 3 (HealthDay News) ... also becomes active in the fat tissue of obese mice ... say researchers. They also found that blocking this signal in ... Previous research found that the CREB pathway keeps blood sugar ...
... breakthrough strategy to improve the effectiveness of the only ... the deadly disease in a pre-clinical test, report scientists ... Houston in Nature Medicine ,s Advance Online Publication ... years of research funded by the National Institutes of ...
... from the Convenience of a Computer, www.CardioCareLive.com takes place entirely ... to 8:00 PM Eastern.,Patch Adams, MD, the real physician behind the ... now for free, visit cardioCareLive.com. , ... Needham, MA ...
Other Medicine News:Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 2Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 3Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 4Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 5Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 6Health News:Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 2Health News:Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 3Health News:Medical Radiation Exposure of the U.S. Population Greatly Increased Since the Early 1980s 2Health News:'Fasting Signal' Offers Clues to Insulin Resistance in the Obese 2Health News:TB breakthrough could lead to stronger vaccine 2Health News:TB breakthrough could lead to stronger vaccine 3Health News:CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today 2
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC ... development of advanced preclinical platforms and tumor specific ... today announced its financial results for the second ... details of Company,s financial results are available in ... ,, Total revenues for the second quarter of ...
(Date:12/15/2009)... the newly formed industry, community and education initiative to ... County, is working to connect the orthopedics capital of ... via high-speed rail. ,, In a September report, ... the World -- An overview, analysis and blueprint ... the statewide initiative to grow Indiana,s unique life sciences ...
(Date:12/15/2009)... 15 Medical researchers with EDP Biotech ... revolutionary new technology for a simple blood test ... Following the success of its pre-clinical trials for ... on the biomarker, CA11-19, and all aspects of ... ColoMarker(TM) will detect colon cancer in its earliest, ...
Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Pharmacy Times Names New Editorial Director 53496 1Pharmacy Times Names New Editorial Director 53496 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 3Five Questions About Protopic 28tacrolimus 29 Ointment 13332 4Why anorexic patients cling to their eating disorder 53489 1Why anorexic patients cling to their eating disorder 53489 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: